3 results
Approved WMOCompleted
The primary objective of this study is to evaluate whether treatment with nesiritide improves patient outcomes (as measured by reduction in the composite of HF rehospitalization and all-cause mortality through 30 days after randomization [Day 30])…
Approved WMOPending
To evaluate the efficacy of crovalimab compared to eculizumab
Approved WMOPending
To evaluate the safety and tolerability of crovalimab compared witheculizumab